Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹94,601.60Qualified | L1 | Qualified MSE, Category: General | |
| 2 | L2₹1.1 L+₹17,465.30 (18.5%)Qualified | L2 | Qualified MSE, Category: General | |
| 3 | ₹75,945Qualified B NO 62 SHAHEED UDHAM SINGH NAGAR JALANDHAR PUNJAB 144001 | JALANDHAR | PUNJAB | 144001 | - | Qualified MSE, Category: General |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
8 Mar 2025, 11:00 amClosed
LACOSAMIDE 100MG TAB
LENALIDOMIDE 10 MG TAB
LENALIDOMIDE 5 MG CAP
LETROZOLE 2.5MG TAB
LEVENORGESTROL 0.25 MG Plus ETHINYLESTRADIOL 0.05MG PACK OF 20 TAB
LEVOCARNITINE 1 GM INJECTION
LEVOSALBUTAMOL 100MCG Plus BECLOMETASONE 100MCG ROTACAP AEROCORT
LEVOSULPIRIDE 25 MG TAB
LEVOSULPIRIDE 75 MG TAB
LEVOSULPRIDE 50 MG TAB
LINAGLIPTIN 2.5MG Plus METFORMIN 1000 MG TAB
LINAGLIPTIN 5MG Plus METFORMIN 1000 MG TAB
LIQ PARAFFIN 100 ML BOTT
LISINOPRIL 2.5 MG TAB
LISINOPRIL 5 MG TAB
LITHIUM CARBONATE 300 MG CAP TAB
LOPERAMIDE 2 MG TAB
LORATADINE 10 MG TAB
LORAZEPAM 1 MG TAB
LORAZEPAM 2 MG INJ
LORAZEPAM 2 MG TAB
L-ORNITHINE L-ASPARTATE TAB HEPAMERZ
LOTEPREDENOL ETABONATE 0.5 percent BOTT OF 5 ML
LULICONAZOLE CREAM
MEDROXY PROGESTRONE 10MG TAB
MEFENAMIC ACID 500 MG TAB
MEGESTROL ACETATE 160MG TAB
MELATONIN 3MG TAB
MEMANTINE 10 MG TAB
MEMANTINE 5MG TAB
MESALAMINE 1 GM SACHET Bid Number ( ) : GEM/2025/B/5955825 Dated : 15-02-2025 Bid Document 1/27
7528959
GEM/2025/B/5955825
Two Packet Bid
MESALAMINE 1 GM SACHET
20 days
Patiala, Punjab
Total value wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹31
50%
Exempted
15 Feb 2025
15 Feb 2025
8 Mar 2025
LACOSAMIDE 100MG TAB
LENALIDOMIDE 10 MG TAB
LENALIDOMIDE 5 MG CAP
LETROZOLE 2.5MG TAB
LEVENORGESTROL 0.25 MG Plus ETHINYLESTRADIOL 0.05MG PACK OF 20 TAB
LEVOCARNITINE 1 GM INJECTION
LEVOSALBUTAMOL 100MCG Plus BECLOMETASONE 100MCG ROTACAP AEROCORT
LEVOSULPIRIDE 25 MG TAB
LEVOSULPIRIDE 75 MG TAB
LEVOSULPRIDE 50 MG TAB
LINAGLIPTIN 2.5MG Plus METFORMIN 1000 MG TAB
LINAGLIPTIN 5MG Plus METFORMIN 1000 MG TAB
LIQ PARAFFIN 100 ML BOTT
LISINOPRIL 2.5 MG TAB
LISINOPRIL 5 MG TAB
LITHIUM CARBONATE 300 MG CAP TAB
LOPERAMIDE 2 MG TAB
LORATADINE 10 MG TAB
LORAZEPAM 1 MG TAB
LORAZEPAM 2 MG INJ
LORAZEPAM 2 MG TAB
L-ORNITHINE L-ASPARTATE TAB HEPAMERZ
LOTEPREDENOL ETABONATE 0.5 percent BOTT OF 5 ML
LULICONAZOLE CREAM
MEDROXY PROGESTRONE 10MG TAB
MEFENAMIC ACID 500 MG TAB
MEGESTROL ACETATE 160MG TAB
MELATONIN 3MG TAB
MEMANTINE 10 MG TAB
MEMANTINE 5MG TAB
MESALAMINE 1 GM SACHET Bid Number ( ) : GEM/2025/B/5955825 Dated : 15-02-2025 Bid Document 1/27
LACOSAMIDE 100MG TAB
LENALIDOMIDE 10 MG TAB
LENALIDOMIDE 5 MG CAP
LETROZOLE 2.5MG TAB
LEVENORGESTROL 0.25 MG Plus ETHINYLESTRADIOL 0.05MG PACK OF 20 TAB
LEVOCARNITINE 1 GM INJECTION
LEVOSALBUTAMOL 100MCG Plus BECLOMETASONE 100MCG ROTACAP AEROCORT
LEVOSULPIRIDE 25 MG TAB
LEVOSULPIRIDE 75 MG TAB
LEVOSULPRIDE 50 MG TAB
LINAGLIPTIN 2.5MG Plus METFORMIN 1000 MG TAB
LINAGLIPTIN 5MG Plus METFORMIN 1000 MG TAB
LIQ PARAFFIN 100 ML BOTT
LISINOPRIL 2.5 MG TAB
LISINOPRIL 5 MG TAB
LITHIUM CARBONATE 300 MG CAP TAB
LOPERAMIDE 2 MG TAB
LORATADINE 10 MG TAB
LORAZEPAM 1 MG TAB
LORAZEPAM 2 MG INJ
LORAZEPAM 2 MG TAB
L-ORNITHINE L-ASPARTATE TAB HEPAMERZ
LOTEPREDENOL ETABONATE 0.5 percent BOTT OF 5 ML
LULICONAZOLE CREAM
MEDROXY PROGESTRONE 10MG TAB
MEFENAMIC ACID 500 MG TAB
MEGESTROL ACETATE 160MG TAB
MELATONIN 3MG TAB
MEMANTINE 10 MG TAB
MEMANTINE 5MG TAB
MESALAMINE 1 GM SACHET
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7528959.pdf
GEM_BID
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
noting100_2025-02-15-10-50-16_278cbfe7571555bb604d12fc84be5c39.pdf
BOQ
boq_item_sample_file100_2025-02-15-10-50-16_215e6286c598582d2d71fe97d6594595.csv.pdf
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .